0
0
6/18/23 at 2:00am
Organization
EurekAlert
30 words
0
Comments
New research shows intravenous treatment with a metallo-beta-lactamase inhibitor can be an effective strategy in fighting antimicrobial resistance.
You are the first to view
https://www.eurekalert.org/news-releases/992617
Create an account
or login to join the discussion